Impaired	0	8	O
apoptosis	9	18	O
of	19	21	O
pulmonary	22	31	B-Cell
endothelial	32	43	I-Cell
cells	44	49	I-Cell
is	50	52	O
associated	53	63	O
with	64	68	O
intimal	69	76	B-Tissue
proliferation	77	90	O
and	91	94	O
irreversibility	95	110	O
of	111	113	O
pulmonary	114	123	O
hypertension	124	136	O
in	137	139	O
congenital	140	150	O
heart	151	156	B-Organ
disease	157	164	O
.	164	165	O

OBJECTIVES	167	177	O
:	177	178	O
This	179	183	O
study	184	189	O
sought	190	196	O
to	197	199	O
assess	200	206	O
the	207	210	O
cellular	211	219	O
and	220	223	O
histologic	224	234	O
basis	235	240	O
of	241	243	O
irreversible	244	256	O
pulmonary	257	266	O
hypertension	267	279	O
(	280	281	O
PHT	281	284	O
)	284	285	O
in	286	288	O
the	289	292	O
clinical	293	301	O
setting	302	309	O
of	310	312	O
congenital	313	323	O
heart	324	329	B-Organ
disease	330	337	O
(	338	339	O
CHD	339	342	O
)	342	343	O
.	343	344	O

BACKGROUND	345	355	O
:	355	356	O
Although	357	365	O
many	366	370	O
children	371	379	B-Organism
with	380	384	O
CHD	385	388	O
develop	389	396	O
pulmonary	397	406	O
vascular	407	415	O
disease	416	423	O
,	423	424	O
it	425	427	O
is	428	430	O
unclear	431	438	O
why	439	442	O
this	443	447	O
complication	448	460	O
is	461	463	O
reversible	464	474	O
after	475	480	O
complete	481	489	O
repair	490	496	O
in	497	499	O
some	500	504	O
cases	505	510	O
but	511	514	O
irreversible	515	527	O
in	528	530	O
others	531	537	O
.	537	538	O

Because	539	546	O
failure	547	554	O
of	555	557	O
endothelial	558	569	B-Cell
cell	570	574	I-Cell
apoptosis	575	584	O
might	585	590	O
lead	591	595	O
to	596	598	O
intimal	599	606	B-Tissue
proliferation	607	620	O
and	621	624	O
lack	625	629	O
of	630	632	O
reversibility	633	646	O
of	647	649	O
PHT	650	653	O
,	653	654	O
we	655	657	O
investigated	658	670	O
this	671	675	O
and	676	679	O
other	680	685	O
key	686	689	O
markers	690	697	O
of	698	700	O
vasoactivity	701	713	O
and	714	717	O
angiogenesis	718	730	O
in	731	733	O
subjects	734	742	O
with	743	747	O
PHT	748	751	O
and	752	755	O
CHD	756	759	O
.	759	760	O

METHODS	761	768	O
:	768	769	O
We	770	772	O
assessed	773	781	O
antiapoptotic	782	795	O
and	796	799	O
proapoptotic	800	812	O
markers	813	820	O
in	821	823	O
vascular	824	832	B-Cell
and	833	836	O
perivascular	837	849	B-Cell
cells	850	855	I-Cell
in	856	858	O
lung	859	863	B-Multi-tissue_structure
biopsy	864	870	I-Multi-tissue_structure
samples	871	878	I-Multi-tissue_structure
from	879	883	O
18	884	886	O
patients	887	895	B-Organism
with	896	900	O
CHD	901	904	O
,	904	905	O
7	906	907	O
with	908	912	O
reversible	913	923	O
and	924	927	O
11	928	930	O
with	931	935	O
irreversible	936	948	O
PHT	949	952	O
,	952	953	O
and	954	957	O
6	958	959	O
control	960	967	O
patients	968	976	B-Organism
.	976	977	O

Immunostaining	978	992	O
for	993	996	O
endothelial	997	1008	B-Gene_or_gene_product
nitric	1009	1015	I-Gene_or_gene_product
oxide	1016	1021	I-Gene_or_gene_product
synthase	1022	1030	I-Gene_or_gene_product
,	1030	1031	O
vascular	1032	1040	B-Gene_or_gene_product
endothelial	1041	1052	I-Gene_or_gene_product
growth	1053	1059	I-Gene_or_gene_product
factor	1060	1066	I-Gene_or_gene_product
,	1066	1067	O
and	1068	1071	O
CD34	1072	1076	B-Gene_or_gene_product
(	1077	1078	O
markers	1078	1085	O
of	1086	1088	O
vasoactivity	1089	1101	O
and	1102	1105	O
neoangiogenesis	1106	1121	O
)	1121	1122	O
was	1123	1126	O
also	1127	1131	O
performed	1132	1141	O
.	1141	1142	O

RESULTS	1143	1150	O
:	1150	1151	O
The	1152	1155	O
antiapoptotic	1156	1169	O
protein	1170	1177	O
Bcl	1178	1181	B-Gene_or_gene_product
-	1181	1182	I-Gene_or_gene_product
2	1182	1183	I-Gene_or_gene_product
was	1184	1187	O
highly	1188	1194	O
expressed	1195	1204	O
by	1205	1207	O
pulmonary	1208	1217	B-Cell
endothelial	1218	1229	I-Cell
cells	1230	1235	I-Cell
in	1236	1238	O
all	1239	1242	O
cases	1243	1248	O
of	1249	1251	O
irreversible	1252	1264	O
PHT	1265	1268	O
but	1269	1272	O
in	1273	1275	O
no	1276	1278	O
cases	1279	1284	O
of	1285	1287	O
reversible	1288	1298	O
PHT	1299	1302	O
,	1302	1303	O
nor	1304	1307	O
in	1308	1310	O
control	1311	1318	O
patients	1319	1327	B-Organism
(	1328	1329	O
p	1329	1330	O
less	1332	1336	O
than	1337	1341	O
0	1343	1344	O
.	1344	1345	O
001	1345	1348	O
)	1348	1349	O
.	1349	1350	O

Intimal	1351	1358	B-Tissue
proliferation	1359	1372	O
was	1373	1376	O
present	1377	1384	O
in	1385	1387	O
10	1388	1390	O
of	1391	1393	O
11	1394	1396	O
irreversible	1397	1409	O
PHT	1410	1413	O
cases	1414	1419	O
,	1419	1420	O
but	1421	1424	O
never	1425	1430	O
observed	1431	1439	O
in	1440	1442	O
reversible	1443	1453	O
PHT	1454	1457	O
(	1458	1459	O
p	1459	1460	O
less	1462	1466	O
than	1467	1471	O
0	1473	1474	O
.	1474	1475	O
001	1475	1478	O
)	1478	1479	O
.	1479	1480	O

Similarly	1481	1490	O
,	1490	1491	O
perivascular	1492	1504	B-Cell
inflammatory	1505	1517	I-Cell
T	1518	1519	I-Cell
-	1519	1520	I-Cell
cells	1520	1525	I-Cell
expressed	1526	1535	O
more	1536	1540	O
antiapoptotic	1541	1554	O
proteins	1555	1563	O
in	1564	1566	O
irreversible	1567	1579	O
PHT	1580	1583	O
(	1584	1585	O
p	1585	1586	O
less	1588	1592	O
than	1593	1597	O
0	1599	1600	O
.	1600	1601	O
01	1601	1603	O
)	1603	1604	O
.	1604	1605	O

Irreversible	1606	1618	O
PHT	1619	1622	O
cases	1623	1628	O
were	1629	1633	O
also	1634	1638	O
more	1639	1643	O
likely	1644	1650	O
to	1651	1653	O
show	1654	1658	O
compensatory	1659	1671	O
upregulation	1672	1684	O
of	1685	1687	O
vascular	1688	1696	B-Gene_or_gene_product
endothelial	1697	1708	I-Gene_or_gene_product
growth	1709	1715	I-Gene_or_gene_product
factor	1716	1722	I-Gene_or_gene_product
and	1723	1726	O
new	1727	1730	O
small	1731	1736	O
vessel	1737	1743	B-Multi-tissue_structure
formation	1744	1753	O
at	1754	1756	O
the	1757	1760	O
sites	1761	1766	O
of	1767	1769	O
native	1770	1776	O
vessel	1777	1783	B-Multi-tissue_structure
stenosis	1784	1792	O
or	1793	1795	O
occlusion	1796	1805	O
(	1806	1807	O
p	1807	1808	O
less	1810	1814	O
than	1815	1819	O
0	1821	1822	O
.	1822	1823	O
001	1823	1826	O
)	1826	1827	O
.	1827	1828	O

CONCLUSIONS	1829	1840	O
:	1840	1841	O
Irreversible	1842	1854	O
PHT	1855	1858	O
is	1859	1861	O
strongly	1862	1870	O
associated	1871	1881	O
with	1882	1886	O
impaired	1887	1895	O
endothelial	1896	1907	B-Cell
cell	1908	1912	I-Cell
apoptosis	1913	1922	O
and	1923	1926	O
antiapoptotic	1927	1940	O
signaling	1941	1950	O
from	1951	1955	O
perivascular	1956	1968	B-Cell
inflammatory	1969	1981	I-Cell
cells	1982	1987	I-Cell
.	1987	1988	O

These	1989	1994	O
changes	1995	2002	O
are	2003	2006	O
associated	2007	2017	O
with	2018	2022	O
intimal	2023	2030	B-Tissue
proliferation	2031	2044	O
and	2045	2048	O
vessel	2049	2055	B-Multi-tissue_structure
narrowing	2056	2065	O
,	2065	2066	O
and	2067	2070	O
thereby	2071	2078	O
may	2079	2082	O
contribute	2083	2093	O
to	2094	2096	O
clinical	2097	2105	O
outcomes	2106	2114	O
associated	2115	2125	O
with	2126	2130	O
pulmonary	2131	2140	O
hypertension	2141	2153	O
.	2153	2154	O

